Compare ANIP & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIP | STC |
|---|---|---|
| Founded | 2001 | 1893 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 1999 | 1994 |
| Metric | ANIP | STC |
|---|---|---|
| Price | $80.50 | $65.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $110.00 | $81.00 |
| AVG Volume (30 Days) | ★ 361.1K | 132.4K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.00% |
| EPS Growth | ★ 419.23 | 55.17 |
| EPS | ★ 1.28 | 0.55 |
| Revenue | $206,547,000.00 | ★ $2,921,636,000.00 |
| Revenue This Year | $21.01 | $13.62 |
| Revenue Next Year | $17.59 | $7.13 |
| P/E Ratio | ★ $61.88 | $115.31 |
| Revenue Growth | 2.47 | ★ 17.32 |
| 52 Week Low | $61.35 | $56.39 |
| 52 Week High | $99.50 | $78.61 |
| Indicator | ANIP | STC |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 47.46 |
| Support Level | $79.69 | $57.11 |
| Resistance Level | $83.61 | $66.06 |
| Average True Range (ATR) | 2.43 | 1.71 |
| MACD | -0.35 | -0.42 |
| Stochastic Oscillator | 63.47 | 47.71 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments: Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.